ITC’s Life Sciences and Technology Centre (LSTC) is developing a nasal spray for COVID-19 prevention for which it has initiated clinical trials. Developed by scientists at ITC (LSTC), the company plans to market the nasal spray under the Savlon brand once it gets all the requisite regulatory approvals. The product has the potential to be effective and safe in preventing infection and transmission of COVID-19 along with the existing measures of hygiene recommended by health authorities.
ITC’s LSTC has been at the core of the company’s drive for science led product innovation to support and build its wide range of product portfolio.
ITC has business a interests in cigarettes, hotels, paperboards and specialty papers, packaging, agribusiness, packaged foods and confectionery, information technology, branded apparel, personal care, stationery, safety matches and other FMCG products.
